Prognostic value of gender and primary tumor location in metastatic colon cancer

Grassadonia, Antonino; Carletti, Erminia; De Luca, Antonella; Vici, Patrizia; Di Lisa, Francesca Sofia; Filomeno, Lorena; Cicero, Giuseppe; De Lellis, Laura; Veschi, Serena; Florio, Rosalba; Brocco, Davide; Di Marino, Pietro; Alberti, Saverio; Gamucci, Teresa; Borrelli, Paola; Cama, Alessandro; Tinari, Nicola

doi:10.7150/jca.85748



International Journal of Biological Sciences

International Journal of Medical Sciences

Theranostics

Journal of Genomics

Nanotheranostics

Global reach, higher impact

Full Text | PDF

J Cancer 2023; 14(15):2751-2758. doi:10.7150/jca.85748 This issue Cite

Research Paper

Prognostic value of gender and primary tumor location in metastatic colon cancer

Antonino Grassadonia^1,✉, Erminia Carletti², Antonella De Luca², Patrizia Vici³, Francesca Sofia Di Lisa³, Lorena Filomeno³, Giuseppe Cicero⁴, Laura De Lellis⁵, Serena Veschi⁵, Rosalba Florio⁵, Davide Brocco⁵, Pietro Di Marino⁶, Saverio Alberti⁷, Teresa Gamucci⁸, Paola Borrelli⁹, Alessandro Cama⁵, Nicola Tinari²

1. Department of Innovative Technologies in Medicine and Dentistry, and Center for Advanced Studies and Technology (CAST), G. D'Annunzio University Chieti-Pescara, 66100 Chieti, Italy.
2. Department of Medical, Oral and Biotechnological Sciences, and Center for Advanced Studies and Technology (CAST), G. D'Annunzio University Chieti-Pescara, 66100 Chieti, Italy.
3. Unit of Phase IV Trials, IRCCS Regina Elena National Cancer Institute, 00144 Rome, Italy.
4. Department of Surgical, Oncological and Oral Sciences, Section of Medical Oncology, University of Palermo, 90133 Palermo, Italy.
5. Department of Pharmacy, G. D'Annunzio University, Chieti-Pescara, 66100 Chieti, Italy.
6. Clinical Oncology, S.S. Annunziata Hospital, 66100 Chieti, Italy.
7. Unit of Medical Genetics, Department of Biomedical Sciences-BIOMORF, University of Messina, 98125 Messina, Italy.
8. Medical Oncology, Sandro Pertini Hospital, 00159 Rome, Italy.
9. Laboratory of Biostatistics, Department of Medical, Oral and Biotechnological Sciences, G. D'Annunzio University Chieti-Pescara, 66100 Chieti, Italy.

Citation:

Grassadonia A, Carletti E, De Luca A, Vici P, Di Lisa FS, Filomeno L, Cicero G, De Lellis L, Veschi S, Florio R, Brocco D, Di Marino P, Alberti S, Gamucci T, Borrelli P, Cama A, Tinari N. Prognostic value of gender and primary tumor location in metastatic colon cancer. J Cancer 2023; 14(15):2751-2758. doi:10.7150/jca.85748. https://www.jcancer.org/v14p2751.htm

Other styles

Abstract

Sex might influence prognosis in patients affected by colorectal cancer. We retrospectively studied a cohort of patients affected by metastatic colon cancer (mCC) stratified by sex and primary tumor location. RAS mutational status was also included in the analysis. Overall, 616 patients met the eligibility criteria, 261 women and 355 men. Neither gender, nor RAS mutational status influenced overall survival (OS) in the entire population. As expected, patients with right-sided colon cancer (RCC) had a significant shorter OS compared to those with left-sided colon cancer (LCC) (21.3 vs 33.1 months, p= 0.002). When the analysis was performed stratifying for gender, RCC retained worse prognosis among men (OS 20.5 vs 33.9 months, p= 0.008), but not among women (p= 0.132). Similarly, the presence of RAS mutations had no prognostic effect in women, but was significantly associate with shorter survival in men (OS 29.5 vs 33.7 months, p= 0.046). In addition, when comparing clinical outcome of women or men according to sidedness and RAS mutational status, RCC was associated with dismal prognosis only in men with RAS mutated tumor (OS 17.2 vs 32.3 months, p= 0.008). Our study highlights the importance of gender in the outcome of patients with mCC.

Keywords: Metastatic colorectal cancer (mCRC), Gender, Tumor location, RAS status, Prognosis

Citation styles

APA

Grassadonia, A., Carletti, E., De Luca, A., Vici, P., Di Lisa, F.S., Filomeno, L., Cicero, G., De Lellis, L., Veschi, S., Florio, R., Brocco, D., Di Marino, P., Alberti, S., Gamucci, T., Borrelli, P., Cama, A., Tinari, N. (2023). Prognostic value of gender and primary tumor location in metastatic colon cancer. Journal of Cancer, 14(15), 2751-2758. https://doi.org/10.7150/jca.85748.

ACS

Grassadonia, A.; Carletti, E.; De Luca, A.; Vici, P.; Di Lisa, F.S.; Filomeno, L.; Cicero, G.; De Lellis, L.; Veschi, S.; Florio, R.; Brocco, D.; Di Marino, P.; Alberti, S.; Gamucci, T.; Borrelli, P.; Cama, A.; Tinari, N. Prognostic value of gender and primary tumor location in metastatic colon cancer. J. Cancer 2023, 14 (15), 2751-2758. DOI: 10.7150/jca.85748.

NLM

CSE

Grassadonia A, Carletti E, De Luca A, Vici P, Di Lisa FS, Filomeno L, Cicero G, De Lellis L, Veschi S, Florio R, Brocco D, Di Marino P, Alberti S, Gamucci T, Borrelli P, Cama A, Tinari N. 2023. Prognostic value of gender and primary tumor location in metastatic colon cancer. J Cancer. 14(15):2751-2758.

This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions.